Introduction {#s1}
============

Menopausal women become deficient in multiple hormones such as estrogen, progesterone, testosterone, and dehydroepiandrosterone (DHEA) [@pone.0105048-Mahmud1]--[@pone.0105048-Newhouse1] with increases in luteinizing hormone (LH), follicle stimulating hormone (FSH), and thyroid stimulating hormone (TSH) [@pone.0105048-Lord1]--[@pone.0105048-Kss1]. All of these hormones have individual as well as inter-related functions in the human body, including pulmonary, cardiovascular, gastrointestinal, and immunological functions [@pone.0105048-Cham1], [@pone.0105048-Wira1]. Aging is continually changing as life expectancy increases, and the decrease in cognition through normal aging processes is of primary clinical interest [@pone.0105048-Newhouse1], [@pone.0105048-Anderer1]. In fact, estrogen deficiency has been proposed as a cause of memory deficits in postmenopausal women [@pone.0105048-Gibbs1]. There are studies that suggest that LH increases after menopause with concomitant decline in cognitive performance [@pone.0105048-Short1]. Chorionic gonadotropin receptors and LH occur in the brain [@pone.0105048-AlHader1]. Thus, levels of LH and FSH may increase low-density lipoprotein receptor-related protein in the brain [@pone.0105048-Gibbs1], [@pone.0105048-Wich1]. Levels of FSH increase dramatically in women during and after menopause and can be lowered with estrogen therapy [@pone.0105048-Gibbs1], [@pone.0105048-Foster1]. Emerging evidence suggests that high TSH levels are associated with a two-fold risk of cognitive decline as well as prevalence of anomalies in musculoskeletal systems [@pone.0105048-Davis1]--[@pone.0105048-Szay1].

Menopause and Leptin {#s1a}
--------------------

Weight gain, and associated leptin level changes during menopause have been demonstrated in numerous cases, as leptin was found to have significant association with metabolic factors when compared to resistin in pre and post-menopausal women [@pone.0105048-Kocyigit1]--[@pone.0105048-Nicklas1]. In particular menopausal status is linked with increased weight gain, increased central fat mass, and abnormal lipid metabolism. One case observed a significant statistical correlation with serum leptin levels and fat mass; abdominal obesity and visceral fat area were positively correlated with serum leptin level [@pone.0105048-Lee1]. Leptin concentration was positively correlated with BMI and weight gain in healthy menopausal women [@pone.0105048-Zhou2]. There is indeed a definitive correlation with plasma leptin levels in peri- and postmenopausal women and weight gain, which suggests that there is a dynamic interaction between plasma leptin and body composition. These changes may further indicate that a significant association with leptin levels and metabolic factors could impact other hormonal composition changes that occur during menopause.

One important question that concerns menopausal women is weight gain and early cognitive decline [@pone.0105048-Zilberman1]. In some studies, researchers have found that obesity-related waist circumference had a positive correlation with global cognition [@pone.0105048-Priya1]. There have been controversial reports indicating that naturally occurring estrogen may have a beneficial effect on cognition in women [@pone.0105048-Nicklas1]--[@pone.0105048-Li1]. There is a strong relationship between the hormone leptin and obesity especially in females [@pone.0105048-Eramudugolla1]--[@pone.0105048-Arnoldussen1]; however, leptin\'s role in cognition has been studied with mixed results [@pone.0105048-Lee1]--[@pone.0105048-Soni1] and there is a notable lack of published data on P300 utilization and its relationship with plasma leptin levels, despite studies indicating the association between leptin and cognitive genes. The P300 evoked potential measures electrical brain waves and their function in particular regions of the brain. It is a diagnostic tool used to identify neurological deficits or abnormalities, such as cognitive decline and neurotransmitter deficiencies.

Moreover delayed P300 latency and obesity are both associated with dementia. Leptin resistance may delay electrophysiological processing of memory and attention. [@pone.0105048-Chen1].

The Clinical Significance of P300 Testing {#s1b}
-----------------------------------------

When used in a clinical setting, the P300 serves as an invaluable resource towards early diagnosis and treatment of poor cognition and loss of brain vitality due to menopausal transition. Analysis of the P300 and standard neuropsychological variables to assess patients with mild cognitive impairment (MCI) and Alzheimer\'s disease can provide valuable information for the detection of MCI and AD [@pone.0105048-Weiner1]. A number of studies determine that there is justification and efficacy in employing more resources unto converting P300 as an acceptable biological marker for AD [@pone.0105048-Parra1]--[@pone.0105048-Polich1]. P300 is responsive to the deterioration of language, memory, and executive functions, thereby acting as a useful tool in evaluating cognitive function [@pone.0105048-Lee2]. The P300 was therefore a suitable tool in evaluating the variations in cognitive function and quality in subjects.

We hypothesized that women presenting with complaints related to menopause would have a number of associated hormonal changes relating specifically to both somatic and neurological symptoms. We also hypothesized that there would be an inverse relationship between plasma leptin levels and P300 speed and voltage based on literature suggesting that as women transition into menopause, they are more likely to gain weight due to associated changes leptin levels, which have been associated with a decrease in cognitive functioning [@pone.0105048-Bove1]--[@pone.0105048-Kocyigit2]. In this paper, we focus on the role of leptin plasma levels and brain electrophysiology as measured by P300 amplitude (voltage) and latency.

Methods {#s2}
=======

Subjects {#s2a}
--------

All female patients who presented to a private clinic, at or approaching the typical age of menopause onset (age 39--59), were examined. We also extended this study to include a small number of women (n = 33) between 35 to 39 years, as well as 10 women ≥60 years. The descriptive distribution summary of each measured variable collected from January 4, 2009 to February 24, 2013 in this retrospective study is as follows: The initial sample size was n = 796 female patients. Missing values are common in this dataset, and certain variables were dichotomized based on the cutoff chart with the normal ranges given. Each patient filled out an approved PATH Foundation NY IRB (PFNYIRB) informed consent form, and the PFNYIRB committee approved the study \[Registration \# IRB00002334; Protocol \#: LEXMEN001\].

All subjects underwent a thorough medical evaluation including a full screen for hormones including DHEA sulfate, estradiol, estrone, FSH, LH, pregnenolone, progesterone, free and total testosterone, and TSH obtained from BioReference Laboratories, Inc. Hormone blood levels were drawn between 9:30 am and 3:00 pm. A detailed medical history was obtained including information on the stage of menopause (pre, undergoing, or post), origin of menopause, and history of hormone replacement therapy as well as anthropometric characteristics such as weight, height, BMI, body fat percentage, muscle, and bone density recorded via duel-energy x-ray absorptiometry (DXA). These anthropometric characteristics were not included in the study\'s final data analysis, but may be considered for future studies. A Menopause Questionnaire ([Figure 1](#pone-0105048-g001){ref-type="fig"}) was given to all women (n = 796) following a preliminary screening. The quantitative section of the Menopause Questionnaire consisted of 64 questions related to symptoms of menopause. Each symptom was rated on a Likert scale of frequency from 1 (never) to 5 (always). The total number of endorsed symptoms was calculated as a gross indicator of menopausal symptomatology. Mean values of the Likert ratings also were calculated within each of 12 domains of symptoms: neurological, neuropsychiatric, neuropsychological, endocrine, pulmonary, musculoskeletal, gastrointestinal, cardiovascular, immune, dermatological, genitourinary, and gynecological. A grand mean of the Likert rating across all domains also was calculated. All reported blood levels and preliminary questionnaires were recorded within 3 weeks of each other.

![Menopause Questionnaire.](pone.0105048.g001){#pone-0105048-g001}

The demographics for the study are outlined in [Table 1](#pone-0105048-t001){ref-type="table"} (subsections A--S). The age range of the patients was 39--76 years (46.7±0.2 years, n = 796) with ∼93.6% of patients between ages 40 and 54 (n = 745); FSH levels were 30.1±1.3 mIU/mL (n = 731) with strong right skewed distribution; LH levels were 19.1±0.7 mIU/mL (n = 726) with strong right skewed distribution; TSH levels were 2.0±0.2 µIU/mL (n = 795) with strong right distribution; leptin levels were 21.0±0.8 ng/mL (n = 565) with strong right skewed distribution; IGF-BP3 levels were 4.4±0.1 µg/mL (n = 306) with moderately normal distribution; Vitamin D 25OH levels were 37.5±0.8 ng/mL (n = 671) with moderately right skewed distribution; Vitamin D 1,25 levels were 61.4±1.1 pg/mL (n = 585) with moderately right skewed distribution; % Free Testosterone, Testosterone Free, and Testosterone Total levels were 2.9±0.4% (n = 26), 0.8±0.1 pg/mL (n = 711), and 30.8±1.5 ng/dL (n = 715), respectively, Testosterone Free and Testosterone Total with strong right skewed distributions; estradiol levels were 97.4±7.4 pg/mL (n = 740) with strong right skewed distribution; estrone levels were 69.7±4.2 pg/mL (n = 522) with strong right skewed distribution; estriol levels were 0.2±0.0 ng/mL (n = 513); ∼24% of patients underwent Brain Electrical Activity Mapping (BEAM) (n = 796); P300 latency levels were 319.7±1.9 ms (n = 194) with moderately normal distribution; and, P300 amplitude levels were 4.8±0.4 µv (n = 194) with strong right skewed distribution.

10.1371/journal.pone.0105048.t001

###### A--S: Demographics of Subjects.
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  ------------------------------------------------------------------------------------------------------------------------------------- ------- ------------
  **A: Age Demographics of Subjects With Age Range of Patients 39--76 years (46.7±0.2 years) (n = 796)**                                        
  Age Group                                                                                                                              Count   Proportion
  2: 35--39                                                                                                                               33      0.04146
  3: 40--44                                                                                                                               217     0.27261
  4: 45--49                                                                                                                               321     0.40327
  5: 50--54                                                                                                                               207     0.26005
  6: 55--59                                                                                                                                8      0.01005
  7: 60--64                                                                                                                                8      0.01005
  A 9: 71+                                                                                                                                 2      0.00251
  Total                                                                                                                                   796        1
  **B: Dichotomized FSH Level Demographics of Subjects with 30.1±1.3 (n = 731) strongly right skewed distribution**                             
  FSH Level Dichotomized                                                                                                                 Count   Proportion
  Pre-menopausal                                                                                                                          428      0.5855
  Post-menopausal                                                                                                                         303      0.4145
  Total                                                                                                                                   731        1
  **C: Demographics for Subjects with FSH Values Below and Over 40**                                                                            
  FSH Value over 40?                                                                                                                     Count   Proportion
  Yes                                                                                                                                     212     0.29001
  No                                                                                                                                      519     0.70999
  Total                                                                                                                                   731        1
  **D: Demographics for Subjects with FSH Values Below and Over 80**                                                                            
  FSH Value over 80?                                                                                                                     Count   Proportion
  Yes                                                                                                                                     92      0.12585
  No                                                                                                                                      639     0.87415
  Total                                                                                                                                   731        1
  **E: Demographics for Subjects with FSH Values Below and Over 100**                                                                           
  FSH Value over 100?                                                                                                                    Count   Proportion
  Yes                                                                                                                                     48      0.06566
  No                                                                                                                                      683     0.93434
  Total                                                                                                                                   731        1
  **F: Dichotomized LH Level Demographics for Subjects (19.1±0.7; n = 726; strongly right skewed distribution)**                                
  LH Level Dichotomized                                                                                                                  Count   Proportion
  Pre-menopausal                                                                                                                          378     0.52066
  Post-menopausal                                                                                                                         348     0.47934
  Total                                                                                                                                   726        1
  **G: Dichotomized TSH Level Demographics for Subjects (2.0±0.2; n = 795; strongly right skewed distribution)**                                
  TSH Level Dichotomized                                                                                                                 Count   Proportion
  Normal                                                                                                                                  728     0.91572
  Abnormal                                                                                                                                67      0.08428
  Total                                                                                                                                   795        1
  **H: Dichotomized Leptin Level Demographics for Subjects (21.0±0.8; n = 565; strongly right skewed distribution)**                            
  Leptin Level Dichotomized                                                                                                              Count   Proportion
  Normal                                                                                                                                  260     0.46018
  Abnormal                                                                                                                                305     0.53982
  Total                                                                                                                                   565        1
  **I: Dichotomized IGF-BP3 Level Demographics for Subjects (4.4±0.1; n = 306; moderately normal distribution)**                                
  IGF-BP3 Level Dichotomized                                                                                                             Count   Proportion
  Normal                                                                                                                                  287     0.93791
  Abnormal                                                                                                                                19      0.06209
  Total                                                                                                                                   306        1
  **J: Dichotomized Vitamin D 250H Level Demographics for Subjects (37.5±0.8; n = 671; moderately right skewed distribution)**                  
  Vitamin D 25OH Level Dichotomized                                                                                                      Count   Proportion
  Normal                                                                                                                                  438     0.65276
  Abnormal                                                                                                                                233     0.34724
  Total                                                                                                                                   671        1
  **K: Dichotomized Vitamin D 1,25 Level Demographics for Subjects (61.4±1.1; n = 585; moderately right skewed distribution)**                  
  Vitamin D 1,25 Level Dichotomized                                                                                                      Count   Proportion
  Normal                                                                                                                                  342     0.58462
  Abnormal                                                                                                                                243     0.41538
  Total                                                                                                                                   585        1
  **L: Dichotomized % Free Testosterone Level Demographics for Subjects (0.8±0.1; n = 711; strongly right skewed distribution)**                
  \% Free Testosterone Level Dichotomized                                                                                                Count   Proportion
  Normal                                                                                                                                  694     0.97609
  Abnormal                                                                                                                                17      0.02391
  Total                                                                                                                                   711        1
  **M: Dichotomized Testosterone Total Level Demographics for Subjects (30.8±1.5; n = 715; strongly right skewed distribution)**                
  Testosterone Total Level Dichotomized                                                                                                  Count   Proportion
  Normal                                                                                                                                  547     0.76503
  Abnormal                                                                                                                                168     0.23497
  Total                                                                                                                                   715        1
  **N: Dichotomized Estradiol Level Demographics for Subjects (97.4±7.4; n = 720; strongly right skewed distribution)**                         
  Estradiol Level Dichotomized                                                                                                           Count   Proportion
  Pre-menopausal                                                                                                                          631     0.87639
  Post-menopausal                                                                                                                         89      0.12361
  Total                                                                                                                                   720        1
  **O: Dichotomized Estrone Level Demographics for Subjects (69.7±4.2; n = 552; strongly right skewed distribution)**                           
  Estrone Level Dichotomized                                                                                                             Count   Proportion
  Pre-menopausal                                                                                                                          354      0.6413
  Post-menopausal                                                                                                                         198      0.3587
  Total                                                                                                                                   552        1
  **P: Dichotomized Estriol Level Demographics for Subjects (0.2±0.0; n = 513)**                                                                
  Estriol Level Dichotomized                                                                                                             Count   Proportion
  Normal                                                                                                                                   1      0.00195
  Abnormal                                                                                                                                512     0.99805
  Total                                                                                                                                   513        1
  **Q: Dichotomized Beam Level Demographics for Subjects**                                                                                      
  Beam Level                                                                                                                             Count   Proportion
  Yes                                                                                                                                     192      0.2409
  No                                                                                                                                      605      0.7591
  Total                                                                                                                                   797        1
  **R: Dichotomized P300 Speed (Latency) Level Demographics for Subjects (319.7±1.9; n = 194) moderately normal distribution)**                 
  P300 Speed (Latency) Level Dichotomized                                                                                                Count   Proportion
  Normal                                                                                                                                  90      0.46392
  Abnormal                                                                                                                                104     0.53608
  Total                                                                                                                                   194        1
  **S: Dichotomized P300 Voltage (Amplitude) Level Demographics for Subjects (4.8±0.4; n = 194; strongly right skewed distribution)**           
  P300 Voltage (Amplitude) Level Dichotomized                                                                                            Count   Proportion
  Normal                                                                                                                                   5      0.02577
  Abnormal                                                                                                                                189     0.97423
  Total                                                                                                                                   194        1
  ------------------------------------------------------------------------------------------------------------------------------------- ------- ------------

Statistical Analysis {#s2b}
--------------------

In order to examine the relationships among the variables, each and every pair of response and explanatory variables were examined using contingency analysis, bivariate scatter plots, simple linear regressions, as well as one-way analysis of variance (ANOVA) or Welch\'s t-test for classification variables. When the test of multiple means turned out to be statistically significant at 5% level, all pairs of means were compared using Tukey-Kramer\'s honestly significant difference as a post-hoc method.

Pearson product-moment correlations were calculated between hormone levels and the 12 mean domain scores, the total number of endorsed systems, and the grand mean across all 64 questions of the Menopause Questionnaire. A one-way ANOVA was performed for the origin of menopause variable for each of the 12 symptom domains, with a Bonferroni correction of p\<.004 required for significance. Given the large number of domains and likely high inter-correlations between them, a factor analysis with principal components extraction and varimax rotation was performed on the 12 mean domain scores. Factor scores were generated for each patient and entered into the correlation analysis with the hormone levels. A similar factor analysis was performed on the hormone levels to reduce redundancy of highly inter-correlated values. Regression analyses were performed to predict the symptom domain score factors from the 15 hormone levels and again using the hormone level factors.

EEG, P300, and Evoked Potentials Data {#s2c}
-------------------------------------

Lexicor and Cognitrace were used to determine P300 potential. A total of twenty electrodes were utilized: 3 along the central sulcus, 3 in the parietal region, 2 in the parietal/temporal region, 3 in the occipital region, 2 in the frontal/temporal region, as well as 5 in the frontal region. Calibration of the two machines was completed by repeat scans. Auditory stimuli of high and low beeps are utilized by Lexicor and Cognitrace with an output of latency and amplitude, dependent on age-based preprogrammed baselines. Listed in the patients\' charts and determined through computer algorithm, latency (in milliseconds) and amplitude (in microvolts) from the waveform were selected for analysis.

Results {#s3}
=======

Preliminary Analyses {#s3a}
--------------------

The detailed results of these preliminary analyses are not shown here due to the length, but they were used in constructing more elaborate multiple regression models and interpreting the results in the Corrected Analysis Section. In particular, the following tables summarize the statistical association of certain variables of interest.

Association between Dichotomized FSH and P300 Speed/Voltage {#s3b}
-----------------------------------------------------------

[Table 2](#pone-0105048-t002){ref-type="table"} outlines the association between FSH and P300 speed/voltage. Latency was correlated with FSH (p = .02), but the fit was very poor (R2 = .02). P300 speed (dichotomized latency) is shown to be uncorrelated with FSH (p = .10). Amplitude or P300 voltage was also uncorrelated with FSH (p = .19).

10.1371/journal.pone.0105048.t002

###### Association between FSH and P300 Speed/Voltage.
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  Test                                                                          Adjusted R2    N      F                       P-Value                      Chi2
  ---------------------------------------------------------------------------- ------------- ----- -------- ------------------------------------------- ----------
  Latency fitted by FSH (Bivariate)                                               0.02662     186   6.0595                   0.0148\*                       \-
  P300 Speed fitted by FSH (Logistic)                                               \-        \-      \-                       0.162                     1.95563
  Amplitude fitted by FSH (Bivariate)                                            −0.00069     186   0.873                     0.3513                        \-
  P300 Voltage fitted by FSH (Logisitic)                                            \-        \-      \-                      0.0759                     3.150917
  Latency fitted by Dichotomozied FSH (ANOVA)                                     0.01976     186   4.7293   0.0309\* (two-sided) 0.0155\* (one-sided)      \-
  P300 Speed fitted by Dichotomized FSH (Contigency) Likelihood Ratio               \-        \-      \-                      0.0972                       2.75
  P300 Speed fitted by Dichotomized FSH (Contigency) Pearson                        \-        \-      \-                      0.0977                      2.742
  P300 Speed fitted by Dichotomized FSH (Contigency) Fisher\'s Exact Test           \-        \-      \-                        \-                        0.1075
  Amplitude fitted by Dichotomized FSH (ANOVA)                                   0.000838     186   1.1551              0.2839 (two-sided)                  \-
  P300 Voltage fitted by Dichotomized FSH (Contingency) Likelihood Ratio            \-        \-      \-                      0.1895                      1.721
  P300 Voltage fitted by Dichotomized FSH (Contingency) Pearson                     \-        \-      \-                      0.2063                      1.597
  P300 Voltage fitted by Dichotomized FSH (Contingency) Fisher\'s Exact Test        \-        \-      \-                      0.3705                        \-

Association between Categorized FSH and P300 Speed/Voltage {#s3c}
----------------------------------------------------------

[Table 3](#pone-0105048-t003){ref-type="table"} outlines the association between categorized FSH range and P300 latency/amplitude (i.e., speed/voltage). P300 speed was uncorrelated with FSH over 40 mIU/mL (or under 40 mIU/mL) (p = .27). Amplitude or P300 voltage also was uncorrelated with FSH over 40 mIU/mL (or under 40 mIU/mL) (p = .18). P300 speed was uncorrelated with FSH over 80 mIU/mL (or under 80 mIU/mL) (p = .65). P300 voltage also was uncorrelated with FSH over 80 mIU/mL (or under 80 mIU/mL) (p = .20). P300 speed was uncorrelated with FSH over 100 mIU/mL (or under 100 mIU/mL) (p = .13). P300 voltage also was uncorrelated with FSH over 100 mIU/mL (or under 100 mIU/mL) (p = .32).

10.1371/journal.pone.0105048.t003

###### Association between Categorized FSH and P300 Speed/Voltage.
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  Test                                                                     Adjusted R2    N      F         t                        P-Value                    Chi2
  ----------------------------------------------------------------------- ------------- ----- -------- ---------- ------------------------------------------- -------
  Latency fitted by FSH over 40 (ANOVA)                                     0.019772     186   4.7316   2.17523    0.0309\* (two sided) 0.0154\* (one-sided)    \-
  P300 Speed fitted by FSH over 40 (Contingency) Likelihood Ratio              \-        \-      \-        \-                       0.2678                     1.228
  P300 Speed fitted by FSH over 40 (Contingency) Pearson                       \-        \-      \-        \-                       0.2689                     1.223
  P300 Speed fitted by FSH over 40 (Contingency) Fisher\'s Exact Test          \-        \-      \-        \-                       0.2785                      \-
  Amplitude fitted by FSH over 40 (ANOVA)                                    0.00413     186   1.7671      \-                 0.1854 (two-sided)                \-
  P300 Voltage fitted by FSH over 40 (Contingency) Likelihood Ratio            \-        \-      \-        \-                      0.0444\*                    4.041
  P300 Voltage fitted by FSH over 40 (Contingency) Pearson                     \-        \-      \-        \-                       0.1133                     2.507
  P300 Voltage fitted by FSH over 40 (Contingency) Fisher\'s Exact Test        \-        \-      \-        \-                        0.174                      \-
  Latency fitted by FSH over 80 (ANOVA)                                     0.007259     186   2.3527      \-                 0.1268 (two-sided)                \-
  P300 Speed fitted by FSH over 80 (Contingency) Likelihood Ratio              \-        \-      \-        \-                       0.6516                     0.204
  P300 Speed fitted by FSH over 80 (Contingency) Pearson                       \-        \-      \-        \-                       0.6522                     0.203
  P300 Speed fitted by FSH over 80 (Contingency) Fisher\'s Exact Test          \-        \-      \-        \-                       0.6862                      \-
  Amplitude fitted by FSH over 80 (ANOVA)                                   -0.00327     186   0.3977      \-                 0.5291 (two-sided)                \-
  P300 Voltage fitted by FSH over 80 (Contingency) Likelihood Ratio            \-        \-      \-        \-                       0.1982                     1.656
  P300 Voltage fitted by FSH over 80 (Contingency) Pearson                     \-        \-      \-        \-                        0.34                      0.911
  Latency fitted by FSH over 100 (ANOVA)                                    0.031206     186   6.9591   2.638016   0.0091\* (two-sided) 0.0045\* (one-sided)    \-
  P300 Speed fitted by FSH over 100 (Contingency) Likelihood Ratio             \-        \-      \-        \-                       0.1258                     2.343
  P300 Speed fitted by FSH over 100 (Contingency) Pearson                      \-        \-      \-        \-                       0.1323                     2.266
  P300 Speed fitted by FSH over 100 (Contingency) Fisher\'s Exact test         \-        \-      \-        \-                       0.2015                      \-
  Amplitude fitted by FSH over 100 (ANOVA)                                   −0.0054     186   0.0061      \-                 0.9376 (two-sided)                \-
  P300 Voltage fitted by FSH over 100 (Contingency) Likelihood Ratio           \-        \-      \-        \-                       0.3241                     0.972
  P300 Voltage fitted by FSH over 100 (Contingency) Pearson                    \-        \-      \-        \-                       0.4722                     0.517

Association between FSH and P300 Speed/Voltage for FSH under/over 80 {#s3d}
--------------------------------------------------------------------

[Tables 4](#pone-0105048-t004){ref-type="table"} and [5](#pone-0105048-t005){ref-type="table"} outline the associations between FSH range and P300 speed/voltage for FSH under/over 80 mIU/mL. Again, P300 speed was uncorrelated with FSH for the group with FSH under 80 mIU/mL (p = .12). P300 Voltage also was uncorrelated with FSH for the group with FSH under 80 mIU/mL (p = .21). Similarly, P300 speed was uncorrelated with FSH for the group with FSH over 80 mIU/mL (p = .36). Amplitude also was uncorrelated with FSH for the group with FSH over 80 mIU/mL (p = .10).

10.1371/journal.pone.0105048.t004

###### Association between FSH and P300 Speed/Voltage for FSH under 80.
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  Test                                     Adjusted R2    N      F      P-value     Chi2
  --------------------------------------- ------------- ----- -------- --------- ----------
  Latency fitted by FSH (bivariate)         0.015967     158   3.5476   0.0615       \-
  P300 Speed fitted by FSH (logistic)          \-        \-      \-     0.1212    2.402083
  Amplitude fitted by FSH (bivariate)       0.000377     158   1.0592    0.305       \-
  P300 Voltage fitted by FSH (logistic)        \-        \-      \-     0.2116    1.560134

10.1371/journal.pone.0105048.t005

###### Association between FSH and P300 Speed/Voltage for FSH over 80.
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  Test                                   Adjusted R2   N      F      P-value     Chi2
  ------------------------------------- ------------- ---- -------- --------- ----------
  Latency fitted by FSH (bivariate)       −0.00906     28   0.7575   0.3921       \-
  P300 Speed fitted by FSH (logistic)        \-        \-     \-     0.3595    0.839701
  Amplitude fitted by FSH (bivariate)     0.063924     28   2.8438   0.1037       \-

Association between FSH and P300 Speed/Voltage for FSH under/over 100 {#s3e}
---------------------------------------------------------------------

[Tables 6](#pone-0105048-t006){ref-type="table"} and [7](#pone-0105048-t007){ref-type="table"} outline the associations between FSH range and P300 speed/voltage for FSH under/over 100 mIU/mL. Again, P300 speed was uncorrelated with FSH for the group with FSH under 100 mIU/mL (p = .29). P300 voltage also was uncorrelated with FSH for the group with FSH under 100 mIU/mL (p = .13). Similarly, P300 speed was uncorrelated with FSH for the group with FSH over 100 mIU/mL (p = .63). Amplitude also was uncorrelated with FSH for the group with FSH over 100 mIU/mL (p = .51).

10.1371/journal.pone.0105048.t006

###### Association between FSH and P300 Speed/Voltage for FSH under 100.
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  Test                                     Adjusted R2    N      F      P-value     Chi2
  --------------------------------------- ------------- ----- -------- --------- ----------
  Latency fitted by FSH (bivariate)         0.000685     169   1.1151   0.2925       \-
  P300 Speed fitted by FSH (logistic)          \-        \-      \-     0.5632    0.33424
  Amplitude fitted by FSH (bivariate)       0.005156     169   1.8706   0.1732       \-
  P300 Voltage fitted by FSH (logistic)        \-        \-      \-     0.1379    2.200685

10.1371/journal.pone.0105048.t007

###### Association between FSH and P300 Speed/Voltage for FSH over 100.
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  Test                                   Adjusted R2   N      F      P-value     Chi2
  ------------------------------------- ------------- ---- -------- --------- ----------
  Latency fitted by FSH (bivariate)       −0.04976     17   0.2416   0.6302       \-
  P300 Speed fitted by FSH (logistic)        \-        \-     \-     0.6857    0.163758
  Amplitude fitted by FSH (bivariate)     −0.03501     17   0.4587   0.5085       \-

Association between FSH over 40 and Estradiol, Estrone, and Estriol {#s3f}
-------------------------------------------------------------------

[Table 8](#pone-0105048-t008){ref-type="table"} outlines the associations between FSH over 40 mIU/mL and estradiol, estrone and estriol. There was a strong association between estradiol and FSH over 40 mIU/mL (or under 40 mIU/mL) (p\<.0001). More explicitly, estradiol level was significantly higher for the group with FSH under 40 mIU/mL (126.0±8.6 pg/mL) than for the group with FSH over 40 mIU/mL (27.1±13.5 pg/mL) (p\<.0001). There was a higher percentage of patients with the pre-menopausal level of estradiol in the group with FSH under 40 mIU/mL than in the group with FSH over 40 mIU/mL (p\<.0001).

10.1371/journal.pone.0105048.t008

###### Association between FSH over 40 and Estradiol, Estrone, Estriol.

![](pone.0105048.t008){#pone-0105048-t008-8}

  Test                                                                               Adjusted R2    N       F         t                         P-value                     Average    Std. Error   Lower 95%   Upper 95%    Chi2
  --------------------------------------------------------------------------------- ------------- ----- --------- ---------- --------------------------------------------- ---------- ------------ ----------- ----------- ---------
  Estradiol fitted by FSH over 40 (ANOVA)                                              0.04977     713   38.2927   −6.18811   \<.0001\* (two-sided) \<.0001\* (one-sided)      \-          \-          \-          \-         \-
  Estradiol fitted by FSH over 40                                                        \-        206     \-         \-                          \-                         27.092      13.48        0.63        53.56       \-
  Estradiol fitted by FSH under 40                                                       \-        507     \-         \-                          \-                         126.01      8.592       109.14      142.88       \-
  Dichotomized Estradiol fitted by FSH over 40 (Contingency) Likelihood Ratio            \-        \-      \-         \-                       \<.0001\*                       \-          \-          \-          \-       100.562
  Dichotomized Estradiol fitted by FSH over 40 (Contingency) Pearson                     \-        \-      \-         \-                       \<.0001\*                       \-          \-          \-          \-       111.681
  Dichotomized Estradiol fitted by FSH over 40 (Contingency) Fisher\'s Exact Test        \-        \-      \-         \-                       \<.0001\*                       \-          \-          \-          \-         \-
  Estrone fitted by FSH over 40 (ANOVA)                                               0.036116     546   21.4206   −4.62824   \<.0001\* (two-sided) \<.0001\* (one-sided)                                                  
  Estrone fitted by FSH over 40                                                          \-        168     \-         \-                          \-                        41.0796      7.5164      26.315      55.844       \-
  Estrone fitted by FSH under 40                                                         \-        378     \-         \-                          \-                        82.8889      5.0109      73.046      92.732       \-
  Dichotomized Estrone fitted by FSH over 40 (Contingency) Likelihood Ratio              \-        \-      \-         \-                       \<.0001\*                       \-          \-          \-          \-       51.146
  Dichotomized Estrone fitted by FSH over 40 (Contingency) Pearson                       \-        \-      \-         \-                       \<.0001\*                       \-          \-          \-          \-       52.243
  Dichotomized Estrone fitted by FSH over 40 (Contingency) Fisher\'s Exact Test          \-        \-      \-         \-                       \<.0001\*                       \-          \-          \-          \-         \-
  Estriol fitted by FSH over 40 (ANOVA)                                               0.005501     507   3.7991    1.949129     0.0518 (two-sided) 0.0259\* (one-sided)        \-          \-          \-          \-         \-
  Estriol fitted by FSH over 40                                                          \-        152     \-         \-                          \-                        0.19625     0.00776       0.181      0.2115       \-
  Estriol fitted by FSH under 40                                                         \-        355     \-         \-                          \-                        0.178169    0.00508      0.16819     0.18815      \-
  Dichotomized Estriol fitted by FSH over 40 (Contingency) Likelihood Ratio              \-        \-      \-         \-                        0.1203                         \-          \-          \-          \-        2.414
  Dichotomized Estriol fitted by FSH over 40 (Contingency) Pearson                       \-        \-      \-         \-                        0.1261                         \-          \-          \-          \-        2.34
  Dichotomized Estriol fitted by FSH over 40 (Contingency) Fisher\'s Exact Test          \-        \-      \-         \-                        0.2998                         \-          \-          \-          \-         \-

Similarly, there was a strong association between estrone and FSH over 40 mIU/mL (or under 40 mIU/mL) (p\<.0001). More explicitly, estrone level was significantly higher for the group with FSH under 40 mIU/mL (82.9±5.0 pg/mL) than for the group with FSH over 40 mIU/mL (41.1±7.5 pg/mL) (p\<.0001). There was a higher percentage of patients with the pre-menopausal level of estrone in the group with FSH under 40 mIU/mL than in the group with FSH over 40 mIU/mL (p\<.0001).

There was a weak association between estriol and FSH over 40 mIU/mL (or under 40 mIU/mL) (p = .03). Estriol level appeared to be slightly higher for the group with FSH over 40 mIU/mL (0.20±0.01 ng/mL) than for the group with FSH under 40 mIU/mL (0.18±0.01 ng/mL). After dichotomization, however, menopausal level of estriol was found to be uncorrelated with FSH over 40 mIU/mL (or under 40 mIU/mL) (p = .12).

[Tables 9](#pone-0105048-t009){ref-type="table"} and [10](#pone-0105048-t010){ref-type="table"} outline the association between FSH and estradiol, estrone, and estriol for FSH under and over 40 mIU/mL. Estriol was uncorrelated with FSH for the group with FSH under 40 mIU/mL (p = .61). Estriol was uncorrelated with FSH for the group with FSH over 40 mIU/mL either (p = .92). Estradiol was strongly associated with FSH for the group with FSH over 40 mIU/mL (p\<.0001). Estrone also was associated with FSH for the group with FSH over 40 mIU/mL (p\<.01).

10.1371/journal.pone.0105048.t009

###### Association between FSH and Estradiol, Estrone, Estriol for FSH under 40.

![](pone.0105048.t009){#pone-0105048-t009-9}

  Test                                               Adjusted R2    N      F      P-value      Chi2
  ------------------------------------------------- ------------- ----- -------- ---------- ----------
  Estradiol fitted by FSH (bivariate)                 0.013439     507   7.8927   0.0052\*      \-
  Dichotomized Estradiol fitted by FSH (logistic)        \-        \-      \-       0.57     0.322627
  Estrone fitted by FSH (bivariate)                   0.008586     378   4.2649   0.0396\*      \-
  Dichotomized Estrone fitted by FSH (logistic)          \-        \-      \-     0.0283\*   4.812526
  Estriol fitted by FSH (bivariate)                   −0.00209     355   0.2614    0.6094       \-

10.1371/journal.pone.0105048.t010

###### Association between FSH and Estradiol, Estrone, Estriol for FSH over 40.

![](pone.0105048.t010){#pone-0105048-t010-10}

  Test                                               Adjusted R2    N       F       P-value      Chi2
  ------------------------------------------------- ------------- ----- --------- ----------- ----------
  Estradiol fitted by FSH (bivariate)                  0.13044     206   31.7514   \<.0001\*      \-
  Dichotomized Estradiol fitted by FSH (logistic)        \-        \-      \-      \<.0001\*   30.51419
  Estrone fitted by FSH (bivariate)                   0.019264     168   4.2803    0.0401\*       \-
  Dichotomized Estrone fitted by FSH (logistic)          \-        \-      \-      0.0035\*    8.534631
  Estriol fitted by FSH (bivariate)                   −0.00661     152    0.009     0.9245        \-
  Dichotomized Estriol fitted by FSH (logistic)          \-        \-      \-       0.9758     0.000924

Association between Leptin and P300 Speed/Voltage {#s3g}
-------------------------------------------------

[Table 11](#pone-0105048-t011){ref-type="table"} outlines the association between leptin and P300 speed/voltage. High leptin levels were determined as\>5 ng/mL and high P300 latencies were bdetermined by a patient\'s age+300 ms (i.e., a patient age 50 should have a P300 latency of 350, so any value greater than 350, shows a delay in latency). P300 speed appeared to be correlated with leptin (p = .01), with higher leptin level associated with abnormal P300 speed (OR = 0.97). However, once dichotomized, this association was insignificant (p = .10). Amplitude or P300 voltage was uncorrelated with leptin (p\>.30). Furthermore, higher leptin levels are indicative of obesity and its risks and delayed latency shows slowed brain speed and attention.

10.1371/journal.pone.0105048.t011

###### Association between Leptin and P300 Speed/Voltage.

![](pone.0105048.t011){#pone-0105048-t011-11}

  Test                                                                           Adjusted R2    N      F           P-value           Chi2
  ----------------------------------------------------------------------------- ------------- ----- -------- -------------------- ----------
  Latency fitted by Leptin (bivariate)                                            0.048107     159   8.985         0.0032\*           \-
  P300 Speed fitted by Leptin (logistic)                                             \-        \-      \-          0.0083\*        6.972178
  Amplitude fitted by Leptin (bivariate)                                          −0.00036     159   0.9426         0.3331            \-
  P300 Voltage fitted by Leptin (logistic)                                           \-        \-      \-           0.7599         0.09338
  Latency fitted by Dichotomized Leptin (ANOVA)                                   0.000685     159   1.1083   0.2941 (two-sided)      \-
  P300 Speed fitted by Dichotomized Leptin (Contingency) Likelihood Ratio            \-        \-      \-           0.1014          2.683
  P300 Speed fitted by Dichotomized Leptin (Contingency) Pearson                     \-        \-      \-           0.1018          2.677
  P300 Speed fitted by Dichotomized Leptin (Contingency) Fisher\'s Exact Test        \-        \-      \-           0.1131            \-
  Amplitude fitted by Dichotomized Leptin (ANOVA)                                 −0.00364     159   0.4273   0.5143 (two-sided)      \-
  P300 Voltage fitted by Dichotomized Leptin (Contingency) Likelihood Ratio          \-        \-      \-           0.8087          0.059
  P300 Voltage fitted by Dichotomized Leptin (Contingency) Pearson                   \-        \-      \-           0.8094          0.058

Regression Analysis {#s3h}
-------------------

In order to assess the pattern of each hormone level on P300 speed/voltage accounting for any (additive) effect of covariate measured in this study such as age, multiple regression models were constructed with P300 speed/voltage as response variables. Final models were then built by reducing the full models through a stepwise regression method. Only the main effects were considered in the model, and dependency among the response variables was not considered for an individual examination of each response variable. The following tables and figures summarize the results of the reduced model fit, ANOVA, and effect estimates, along with prediction profiler of main effects in the reduced model.

Latency predicted by Leptin with Age (ANOVA) and P300 Speed predicted by Leptin with Age (Logistic) {#s3i}
---------------------------------------------------------------------------------------------------

Once age adjusted, leptin was found to be the only statistically significant predictor for latency or P300 amplitude (p = .03), with the effect size of 0.23. Hence, the higher the leptin level, the longer the latency. After age adjustment, higher leptin level was more associated with abnormal P300 latency (OR = 0.98). Age alone also was a statistically significant factor for latency or P300 speed (p\<.01): the older the patient, the longer was the latency. However, even after age adjustment, amplitude and P300 voltage were found to be uncorrelated with leptin (p\>.25). Also, once age adjusted, none of FSH, LH, or TSH were found to be statistically significant predictors of the P300 measures (p\>.25) (see [Tables 12](#pone-0105048-t012){ref-type="table"}--[16](#pone-0105048-t016){ref-type="table"} and [Figure 2](#pone-0105048-g002){ref-type="fig"}).

![Prediction Profiler for Latency predicted by Leptin with Age (ANOVA).](pone.0105048.g002){#pone-0105048-g002}

10.1371/journal.pone.0105048.t012

###### Latency Variables predicted by Leptin with Age (ANOVA).

![](pone.0105048.t012){#pone-0105048-t012-12}

  Test                                              R2     Adjusted R2    N      F      P-value
  ---------------------------------------------- -------- ------------- ----- ------- -----------
  Latency predicted by Leptin with Age (ANOVA)    0.1573    0.140884     158   9.582   \<.0001\*

10.1371/journal.pone.0105048.t013

###### Regression Analysis of Latency predicted by Leptin with Age (ANOVA).

![](pone.0105048.t013){#pone-0105048-t013-13}

  Parameter Estimates Term     Estimate    Std.Error     t      P-value    Lower 95%   Upper 95%
  --------------------------- ----------- ----------- ------- ----------- ----------- -----------
  Intercept                    322.37092   4.244617    75.95   \<.0001\*   313.98573   330.75611
  Leptin                       0.2306531    0.10853    2.13    0.0352\*    0.0162537   0.4450526
  Age Group: 2&3&4&5--6&7&9    −12.66445   3.382663    −3.74   0.0003\*    −19.34686   −5.982038
  Age Group: 2&3--4&5          −5.758462    2.11586    −2.72   0.0072\*    −9.938319   −1.578605

10.1371/journal.pone.0105048.t014

###### P300 Speed Variables predicted by Leptin with Age (logistic).

![](pone.0105048.t014){#pone-0105048-t014-14}

  Test                                                  N      Chi2      P-value
  --------------------------------------------------- ----- ---------- -----------
  P300 Speed predicted by Leptin with Age(logistic)    158   18.57717   \<.0001\*

10.1371/journal.pone.0105048.t015

###### Regression Analysis of P300 Speed predicted by Leptin with Age (logistic).

![](pone.0105048.t015){#pone-0105048-t015-15}

  Parameter Estimates Term      Estimate    Std.Error     t     P-value    Lower 95%    Upper 95%
  --------------------------- ------------ ----------- ------- ---------- ------------ ------------
  Intercept                    −0.5940827   0.2620591   5.14    0.0234\*   −1.1230387   −0.0913201
  Leptin                       0.02216648   0.0100457   4.87    0.0273\*   0.00320555   0.04286365
  Age Group: 2&3--4&5&6&7&9    −0.6206882   0.1834263   11.45   0.0007\*   −0.9905093   −0.2683189

10.1371/journal.pone.0105048.t016

###### P300 Speed Odds Ratio predicted by Leptin with Age (logistic).

![](pone.0105048.t016){#pone-0105048-t016-16}

  Odd Ratios Term              Odds Ratio   Lower 95%   Upper 95%   Reciprocal
  --------------------------- ------------ ----------- ----------- ------------
  Leptin                        1.022414    1.003211    1.043796    0.9780774
  Age Group: 2&3--4&5&6&7&9     0.537574    0.371387    0.764664    1.8602078

Principal Component Analysis {#s3j}
----------------------------

The principal component analysis (factor analysis) was performed to derive a small number of independent linear combinations (viz., principal components) of a set of variables that capture as much of the variability in the original variables as possible. Reducing the dimensionalities of this multivariate data, the most important components were used to visualize the structure of the data. Each principal component was calculated by taking a linear combination of an eigenvector of the correlation matrix with a variable. The corresponding eigenvalues were the variance of each component.

Principal Component Analysis in the Raw Scale {#s3k}
---------------------------------------------

The proportion of variation explained by clustering was 0.413. The first two principal components accounted for 31.7% of the variability while the first three components accounted for 43.3% of the variability. Based on these components, clustering of the variables was done producing three clusters, each with five variables. There was no distinct or definite association found among the variables (at least the ones being examined). One of the causes was the incompleteness of the data, with many missing values, along with the retrospective aspect of the study. Although some variables tended to have a sizable R2, those strongly right skewed variables from the raw data in a continuous scale were log-transformed to re-perform the principal component analysis to determine possible additional results (see [Tables 17](#pone-0105048-t017){ref-type="table"}--[21](#pone-0105048-t021){ref-type="table"}; [Figures 3](#pone-0105048-g003){ref-type="fig"}, [4](#pone-0105048-g004){ref-type="fig"}).

![Principal Component Analysis in the Raw Scale Eigenvalue Plot.](pone.0105048.g003){#pone-0105048-g003}

![Principal Component Analysis in the Raw Scale Score and Loading Plot.](pone.0105048.g004){#pone-0105048-g004}

10.1371/journal.pone.0105048.t017

###### Principal Component Analysis in the Raw Scale Correlations Estimated by Pairwise Method.

![](pone.0105048.t017){#pone-0105048-t017-17}

                          Age       FSH       LH        TSH     Leptin    IGF-BP3   Vitamin D 25OH   Vitamin D 1,25   Testosterone Free   Testosterone Total   Estradiol   Estrone   Estriol   P300 Latency   P300 Amplitude
  -------------------- --------- --------- --------- --------- --------- --------- ---------------- ---------------- ------------------- -------------------- ----------- --------- --------- -------------- ----------------
  Age                      1      0.4089    0.3833    0.0212    0.0491    −0.1876       0.0285           0.0185            0.0456               0.0471          −0.0623    −0.0243   0.0475       0.3349         −0.0062
  FSH                   0.4089       1       0.855    0.0188    −0.0065   0.0676        0.0051           0.0013            −0.0282             −0.0848          −0.2378    −0.2036   0.0685       0.1786         −0.0687
  LH                    0.3833     0.855       1      0.0456    0.0531    0.0337        0.0213          −0.0252            0.0135              −0.0431          −0.159     −0.1531   0.0635       0.2161         −0.0605
  TSH                   0.0212    0.0188    0.0456       1      0.0861    −0.1212      −0.0426          −0.1096            −0.0099             −0.0109          −0.0168    −0.0229   −0.0505      0.0286          0.0314
  Leptin                0.0491    −0.0065   0.0531    0.0861       1      0.0089       −0.3006          −0.2316            0.0141               0.1042          −0.0135    0.0942    0.1898       0.2327          0.0773
  IGF-BP3               −0.1876   0.0676    0.0337    −0.1212   0.0089       1          0.0375           0.1707            0.0553               0.0029          −0.1208    −0.0747   0.0538      −0.1793          0.1971
  Vitamin D 25OH        0.0285    0.0051    0.0213    −0.0426   −0.3006   0.0375          1              0.4501            0.0149               0.0463          0.0211     −0.0437   −0.1422     −0.0048          0.0313
  Vitamin D 1,25        0.0185    0.0013    −0.0252   −0.1096   −0.2316   0.1707        0.4501             1               0.0278               0.0514          0.1066     0.1357    0.0964      −0.0093         −0.0129
  Testosterone Free     0.0456    −0.0282   0.0135    −0.0099   0.0141    0.0553        0.0149           0.0278               1                 0.3713          0.0535     0.0678    0.0102       0.067           0.0027
  Testosterone Total    0.0471    −0.0848   −0.0431   −0.0109   0.1042    0.0029        0.0463           0.0514            0.3713                 1             0.3284     0.4243    0.1873       0.1572          −0.015
  Estradiol             −0.0623   −0.2378   −0.159    −0.0168   −0.0135   −0.1208       0.0211           0.1066            0.0535               0.3284             1       0.8814    0.0845      −0.0129          0.1637
  Estrone               −0.0243   −0.2036   −0.1531   −0.0229   0.0942    −0.0747      −0.0437           0.1357            0.0678               0.4243          0.8814        1      0.1776       0.0289          0.1819
  Estriol               0.0475    0.0685    0.0635    −0.0505   0.1898    0.0538       −0.1422           0.0964            0.0102               0.1873          0.0845     0.1776       1         0.1752          0.1386
  P300 Latency          0.3349    0.1786    0.2161    0.0286    0.2327    −0.1793      −0.0048          −0.0093             0.067               0.1572          −0.0129    0.0289    0.1752         1            −0.0019
  P300 Amplitude        −0.0062   −0.0687   −0.0605   0.0314    0.0773    0.1971        0.0313          −0.0129            0.0027               −0.015          0.1637     0.1819    0.1386      −0.0019            1

10.1371/journal.pone.0105048.t018

###### Principal Component Analysis in the Raw Scale Eigenvalues.

![](pone.0105048.t018){#pone-0105048-t018-18}

  Number    Eigenvalue   Percent   Cumulative Percent    Chi2       DF       P-value
  -------- ------------ --------- -------------------- --------- --------- -----------
  1           2.592       17.28          17.28          3675.13   104.201   \<.0001\*
  2           2.1618     14.412          31.692         3088.95   94.006    \<.0001\*
  3           1.7409     11.606          43.298         2585.9    83.647    \<.0001\*
  4           1.345       8.967          52.265         2203.61    73.1     \<.0001\*
  5           1.1998      7.999          60.264         1968.51   62.613    \<.0001\*
  6           1.0451      6.967          67.231         1754.61    52.88    \<.0001\*
  7           1.0085      6.724          73.955         1575.81    43.82    \<.0001\*
  8           0.8587      5.725          79.679         1353.07   35.394    \<.0001\*
  9           0.7376      4.918          84.597         1164.67   27.732    \<.0001\*
  10          0.5945      3.963          88.56          998.46    20.907    \<.0001\*
  11          0.5553      3.702          92.262         886.619   14.907    \<.0001\*
  12          0.5431      3.621          95.883         736.788    9.894    \<.0001\*
  13          0.3825      2.55           98.433         420.531    5.908    \<.0001\*
  14          0.1394      0.93           99.363         27.714     2.852    \<.0001\*
  15          0.0956      0.637           100             \-         .         \-

10.1371/journal.pone.0105048.t019

###### Principal Component Analysis in the Raw Scale Variable Clustering Summary.

![](pone.0105048.t019){#pone-0105048-t019-19}

  Cluster    Number of Members   Most Representative Variable   Proportion of Variation Explained
  --------- ------------------- ------------------------------ -----------------------------------
  1                  5                        LH                              0.453
  2                  5                     Estrone                            0.443
  3                  5                  Vitamin D 25OH                        0.342

10.1371/journal.pone.0105048.t020

###### Principal Component Analysis in the Raw Scale Cluster Members.

![](pone.0105048.t020){#pone-0105048-t020-20}

  Cluster         Members         R2 with Own Cluster   R2 with Next Closest   1-R2 Ratio
  --------- -------------------- --------------------- ---------------------- ------------
  1                  LH                  0.779                 0.021             0.226
                    FSH                  0.776                 0.047             0.235
                    Age                  0.478                   0               0.522
                  Latency                0.223                 0.015             0.789
                  IGF-BP3                0.01                  0.009             0.999
  2               Estrone                0.856                 0.019             0.147
                 Estradiol               0.795                 0.029             0.212
             Testosterone Total          0.42                    0                0.58
             Testosterone Free           0.084                   0               0.917
                 Amplitude               0.063                 0.004             0.941
  3            Vitamin D 25OH            0.64                    0                0.36
               Vitamin D 1,25            0.53                  0.014             0.477
                   Leptin                0.44                  0.007             0.564
                    TSH                  0.051                 0.002             0.951
                  Estriol                0.05                  0.032             0.982

10.1371/journal.pone.0105048.t021

###### Principal Component Analysis in the Raw Scale Standardized Components.

![](pone.0105048.t021){#pone-0105048-t021-21}

  Variable              Cluster 1   Cluster 2   Cluster 3
  -------------------- ----------- ----------- -----------
  Age                   0.4593895       0           0
  FSH                   0.5852787       0           0
  LH                    0.5863316       0           0
  TSH                       0           0       −0.172013
  Leptin                    0           0       −0.506993
  IGF-BP3               −0.065645       0           0
  Vitamin D 25OH            0           0       0.6119382
  Vitamin D 1,25            0           0       0.5566771
  Testosterone Free         0       0.194114        0
  Testosterone Total        0       0.4353115       0
  Estradiol                 0       0.598654        0
  Estrone                   0       0.6213278       0
  Estriol                   0           0       −0.170329
  Latency               0.3135539       0           0
  Amplitude                 0       0.1684897       0

Principal Component Analysis in the Log Scale {#s3l}
---------------------------------------------

The first two principal components accounted for 34.1% of the variability, while the first three components accounted for 45.7% of the variability, slightly better than the previous result in the raw scale. Based on these components, clustering of the variables was done producing five clusters, each with a varying number of variables. With an increased number of clusters, each cluster had even fewer associated variables. This confirmed the findings of no clear associations among the variables (among those being examined) and the results of regression analyses. Even in the log scale, some variables were still clustered together. FSH and LH were found to be associated while Vitamin D 1,25 and Vitamin D 25 OH tended to be together. Also, P300 latency and log leptin were found to be associated in the same cluster (see [Tables 22](#pone-0105048-t022){ref-type="table"}--[25](#pone-0105048-t025){ref-type="table"}; [Figures 5](#pone-0105048-g005){ref-type="fig"}, [6](#pone-0105048-g006){ref-type="fig"}).

![Principal Component Analysis in the Log Scale Eigenvalue Plot.](pone.0105048.g005){#pone-0105048-g005}

![Principal Component Analysis in the Log Scale Score and Loading Plot.](pone.0105048.g006){#pone-0105048-g006}

10.1371/journal.pone.0105048.t022

###### Principal Component Analysis in the Log Scale Correlations Estimated by Pairwise Method.

![](pone.0105048.t022){#pone-0105048-t022-22}

                              Age     log FSH   log LH    log TSH   log Leptin   IGF-BP3   log Vitamin D 25OH   log Vitamin D 1,25   log Testosterone Free   log Testosterone Total   log Estradiol   log Estrone   log Estriol   P300 Latency   log P300 Amplitude
  ------------------------ --------- --------- --------- --------- ------------ --------- -------------------- -------------------- ----------------------- ------------------------ --------------- ------------- ------------- -------------- --------------------
  Age                          1      0.4881     0.409    −0.0145     0.0703     −0.1876         0.0427               0.0276                0.0577                   0.0153              −0.2272        −0.1179       0.0348         0.3349           −0.0551
  log FSH                   0.4881       1      0.9034    −0.0002     0.0654     0.0219         −0.0343              −0.0615                −0.0069                 −0.0804              −0.5312        −0.3933       0.0385         0.1488           −0.1109
  log LH                     0.409    0.9034       1      0.0128      0.1233     0.0134         −0.0507              −0.1047                0.0008                  −0.0281              −0.2988        −0.2568       0.0559         0.1629            −0.086
  log TSH                   −0.0145   −0.0002   0.0128       1        0.0563     −0.1445        −0.0747              −0.0622                −0.0087                 −0.1286              −0.0267        −0.0712       −0.038        −0.0535            0.0254
  log Leptin                0.0703    0.0654    0.1233    0.0563        1        0.0368          −0.372              −0.2557                0.0666                   0.1137              −0.0967        0.1198        0.2249         0.2878            −0.124
  IGF-BP3                   −0.1876   0.0219    0.0134    −0.1445     0.0368        1            0.0179               0.188                 0.1104                   0.0185              −0.1823        −0.0768       0.0919        −0.1793            0.256
  log Vitamin D 25OH        0.0427    −0.0343   −0.0507   −0.0747     −0.372     0.0179            1                  0.445                 −0.0519                 −0.0004              0.0534         −0.0968       −0.1206        0.0314            0.0362
  log Vitamin D 1,25        0.0276    −0.0615   −0.1047   −0.0622    −0.2557      0.188          0.445                  1                    0.037                   0.0988              0.0252         0.0454        0.1083         0.0168            0.0939
  log Testosterone Free     0.0577    −0.0069   0.0008    −0.0087     0.0666     0.1104         −0.0519               0.037                    1                     0.4632              0.1064         0.1742        0.1082         0.0966            0.0816
  log Testosterone Total    0.0153    −0.0804   −0.0281   −0.1286     0.1137     0.0185         −0.0004               0.0988                0.4632                     1                 0.2736         0.3963        0.2832         0.1846            0.0303
  log Estradiol             −0.2272   −0.5312   −0.2988   −0.0267    −0.0967     −0.1823         0.0534               0.0252                0.1064                   0.2736                 1           0.6419        0.0133        −0.0557            0.0696
  log Estrone               −0.1179   −0.3933   −0.2568   −0.0712     0.1198     −0.0768        −0.0968               0.0454                0.1742                   0.3963              0.6419            1          0.3282         0.0728            0.0222
  log Estriol               0.0348    0.0385    0.0559    −0.038      0.2249     0.0919         −0.1206               0.1083                0.1082                   0.2832              0.0133         0.3282           1           0.1453            0.1198
  P300 Latency              0.3349    0.1488    0.1629    −0.0535     0.2878     −0.1793         0.0314               0.0168                0.0966                   0.1846              −0.0557        0.0728        0.1453           1              −0.1278
  log P300 Amplitude        −0.0551   −0.1109   −0.086    0.0254      −0.124      0.256          0.0362               0.0939                0.0816                   0.0303              0.0696         0.0222        0.1198        −0.1278              1

10.1371/journal.pone.0105048.t023

###### Principal Component Analysis in the Log Scale Eigenvalues.

![](pone.0105048.t023){#pone-0105048-t023-23}

  Number    Eigenvalue   Percent   Cumulative Percent    Chi2       DF       P-value
  -------- ------------ --------- -------------------- --------- --------- -----------
  1           2.9257     19.505          19.505         4057.56   104.433   \<.0001\*
  2           2.182      14.547          34.051         3265.1    94.786    \<.0001\*
  3           1.743       11.62          45.672         2709.8    84.338    \<.0001\*
  4           1.4633      9.755          55.427         2284.04   73.744    \<.0001\*
  5           1.0488      6.992          62.419         1925.5    63.375    \<.0001\*
  6           1.0103      6.736          69.154         1760.28   53.245    \<.0001\*
  7           0.9309      6.206          75.36          1565.27   43.927    \<.0001\*
  8           0.8221      5.481          80.841         1358.58   35.545    \<.0001\*
  9           0.654       4.36           85.201         1160.88   27.874    \<.0001\*
  10          0.5703      3.802          89.003         1035.24   21.008    \<.0001\*
  11          0.464       3.093          92.097         924.225   14.962    \<.0001\*
  12          0.4505      3.003           95.1          854.797    9.884    \<.0001\*
  13           0.42        2.8            97.9          734.788    5.813    \<.0001\*
  14          0.2629      1.753          99.653         464.47     2.814    \<.0001\*
  15          0.0521      0.347           100              0       0.03      0.3172

10.1371/journal.pone.0105048.t024

###### Principal Component Analysis in the Log Scale Cluster Members.
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  Cluster           Members           R2 with Own Cluster   R2 with Next Closest   1-R2 Ratio
  --------- ------------------------ --------------------- ---------------------- ------------
  1                 log FSH                  0.924                 0.028             0.079
                     log LH                  0.775                 0.032             0.233
                      Age                    0.419                 0.064              0.62
                 log Estradiol               0.379                 0.153             0.734
             log Testosterone Total          0.673                 0.035             0.339
  2          log Testosterone Free           0.381                 0.015             0.629
                  log Estrone                0.484                 0.186             0.634
                  log Estriol                0.34                  0.053             0.697
                    log TSH                  0.04                  0.006             0.967
               log Vitamin D 1,25            0.723                 0.032             0.287
  3            log Vitamin D 25OH            0.723                 0.045             0.291
                    Latency                  0.644                 0.046             0.373
                   log Leptin                0.644                 0.136             0.412
                    IGF-BP3                  0.628                 0.015             0.378
                    Estriol                  0.05                  0.032             0.982

10.1371/journal.pone.0105048.t025

###### Principal Component Analysis in the Log Scale Standardized Components.
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  Variable                  Cluster 1 Coefficients   Cluster 2 Coefficients   Cluster 3 Coefficients
  ------------------------ ------------------------ ------------------------ ------------------------
  Age                             0.4098452                    0                        0
  log FSH                         0.6082957                    0                        0
  log LH                          0.5570797                    0                        0
  log TSH                             0                     −0.14372                    0
  log Leptin                          0                        0                        0
  IGF-BP3                             0                        0                        0
  log Vitamin D 25OH                  0                        0                    0.7071068
  log Vitamin D 1,25                  0                        0                    0.7071068
  log Testosterone Free               0                    0.4456279                    0
  log Testosterone Total              0                    0.5923475                    0
  log Estradiol                   −0.389443                    0                        0
  log Estrone                         0                     0.502436                    0
  log Estriol                         0                    0.4212397                    0
  Latency                             0                        0                        0

K-Means Clustering Analysis {#s3m}
---------------------------

As an alternative clustering analysis, the K-means clustering analysis with K = 2 was performed in the log scale of selected variables, which were strongly right skewed. Initially, the hierarchical clustering was performed to produce a tree-like classification structure, but no distinctive branches could be located to cluster the data in an effective way. In the K-means clustering, many different numbers of clusters were tried, but the two-means seemed to produce the most reasonable outcome, given the incompleteness of the dataset. The variables were scaled individually, and the within-cluster standard deviations were used producing cubic clustering criterion = −4.9793. Each cluster contained 31 and 45 points, respectively. The most representative variable separating these two clusters was log FSH, followed by log LH. The data resolution was found to be weak over other variables; see the scatterplot matrix below. With aforementioned reasons, nevertheless, the clustering was not highly successful with this dataset as the points were scattered without distinctive associations. Although the data were forced to cluster into two here, the parallel coordinate plots showed that the variable patterns were quite similar between the two groups, comparable to the overall cluster means, which resulted in low resolution of clustering (see [Tables 26](#pone-0105048-t026){ref-type="table"}--[30](#pone-0105048-t030){ref-type="table"}; [Figures 7](#pone-0105048-g007){ref-type="fig"}--[10](#pone-0105048-g010){ref-type="fig"}).

![K-Means Clustering Analysis Cluster Bi-Plot.](pone.0105048.g007){#pone-0105048-g007}

![K-Means Clustering Analysis Cluster Bi-Plot in 3D.](pone.0105048.g008){#pone-0105048-g008}

![K-Means Clustering Analysis Parallel Coordinate Plot.](pone.0105048.g009){#pone-0105048-g009}

![K-Means Clustering Analysis Scatter Plot Matrix.](pone.0105048.g010){#pone-0105048-g010}

10.1371/journal.pone.0105048.t026

###### K-Means Clustering Analysis Cluster Summary.
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  Cluster    Count
  --------- -------
  1           31
  2           45

10.1371/journal.pone.0105048.t027

###### K-Means Clustering Analysis Cluster Averages by Variable (Age+Specified Hormones).
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  Cluster       Age        log FSH       log LH      log TSH     log Leptin    IGF-BP3     log Vitamin D 25OH   log Vitamin D 1,25
  --------- ------------ ------------ ------------ ------------ ------------ ------------ -------------------- --------------------
  1          50.4193548   3.84692834   3.33115457   0.07086968   2.62396293   4.40645161       3.37464635           3.83294885
  2          44.4444444   1.60898738   1.40340109   0.37980236   2.14941452   4.52888889       3.55641941           4.05081038

10.1371/journal.pone.0105048.t028

###### K-Means Clustering Analysis Cluster Averages by Variable (Specified Hormones+P300).
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  Cluster    log Testosterone Free   log Testosterone Total   log Estradiol   log Estrone   log Estriol   P300 Latency   log P300 Amplitude
  --------- ----------------------- ------------------------ --------------- ------------- ------------- -------------- --------------------
  1                −0.432203               2.6949935           3.08398269     3.52383408    −2.1642274     318.480645        1.28841661
  2               −0.4176911               2.84516834          4.33986953     3.86399908    −2.3025851     309.948889        1.37825673

10.1371/journal.pone.0105048.t029

###### K-Means Clustering Analysis Cluster Standard Deviations by Variable (Age+Specified Hormones).
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  Cluster       Age        log FSH       log LH      log TSH     log Leptin    IGF-BP3     log Vitamin D 25OH   log Vitamin D 1,25
  --------- ------------ ------------ ------------ ------------ ------------ ------------ -------------------- --------------------
  1          5.13541903   0.81303646   0.67265226   1.2872815    1.09259949   1.06587401       0.50428182           0.45624656
  2          3.49320328   0.53294581   1.08362395   0.63573686   1.20339793   0.68268171       0.53741888           0.43474834

10.1371/journal.pone.0105048.t030

###### K-Means Clustering Analysis Cluster Standard Deviations by Variable (Specified Hormones+P300).
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  Cluster    log Testosterone Free   log Testosterone Total   log Estradiol   log Estrone   log Estriol   P300 Latency   log P300 Amplitude
  --------- ----------------------- ------------------------ --------------- ------------- ------------- -------------- --------------------
  1               0.21883302               0.87241656          1.24017776      0.6873002    0.47147219     31.8035443        0.64528174
  2               0.28383649               0.85136274          0.87015612     0.56004314     1.33E-15      21.0254938        0.38876941

Discussion {#s4}
==========

Although our data did not support a significant association between sex hormones and the electrophysiological parameters examined, most importantly, we did find a significant association between plasma increased leptin levels and P300 latency. Leptin was found to be the only statistically significant predictor for latency or P300 speed. Thus, the higher the leptin level was, the longer was the latency. After age adjustment, higher leptin level was associated more with abnormal P300 speed. While we found that age alone was a statistically significant factor for latency or P300 speed, we inferred that the older the patient was, the longer was the latency. However, even after age adjustment, amplitude and P300 voltage were found to be uncorrelated with leptin. Also, once age was adjusted, none of the FSH, LH, and TSH levels were found to be statistically significant predictors for P300 speed and voltage despite some research suggesting otherwise. In particular, Davis *et al.* [@pone.0105048-Davis1] found that triiodothyronine (T~3~) levels were much lower in advanced AD Braak stages V--VI. Short *et al.* [@pone.0105048-Short1] also found significantly increased levels of LH and GRH in estrogen-free AD patients. In spite of our results, there is a historical positive correlation between the fluctuation in specific sex hormones (e.g. T3, LH, GRH, etc.) and advanced stages of AD, which should be further investigated in future studies elucidating such effects.

There is also significant evidence showing that P300 evoked potentials and neurophysiological tests validate PET measures of brain metabolism in cognitively impaired patients [@pone.0105048-Ajala1]. P300 has important clinical utility in that its measurements are representative of cognitive decline, especially those patients who are already suffering from progressive cognitive impairments or dementia. Reduced P300 amplitudes, delayed latencies, and neuropsychological deficits show positive correlations with PET brain hypometabolism; thus, the P300 serves as a cost-effective indicator that is essential in primary care settings and may help determine early abnormalities in cognition.

These findings may be useful in determining the role of leptin in future studies focusing on obesity and cognition. Certainly there is enough evidence to link leptin plasma levels as a function of cellular resistance and obesity [@pone.0105048-Thurston1], especially in menopausal women [@pone.0105048-Jones1]. While this is fairly clear, less is known concerning the role of leptin and cognition.

There have been studies suggesting that obesity and excessive weight in middle aged adults is a risk factor for cognitive decline later in life [@pone.0105048-Whitmer1]--[@pone.0105048-Beydoun1]; congruently, observational studies of Alzheimer\'s Disease (AD) patients provides potential links between adipose tissue metabolism and cognition, weight loss occurring some years prior to the onset of clinical AD symptoms [@pone.0105048-Hassing1], [@pone.0105048-Buchman1]. The adipokine leptin, a cytokine secreted by adipose tissue, serves as an appetite suppressor and helps to regulate the body\'s energy expenditure--increased plasma levels of leptin associated with excessive body fat [@pone.0105048-Cronk1].

Mouse models have linked disrupted leptin receptors as potential sources for long-term potentiation impairments, synaptic plasticity issues, and deficiencies in spatial learning [@pone.0105048-Razay1]. Furthermore, hippocampal viral vector introduction of leptin in rodents induced neuronal precursor proliferation and reduced neuro-degeneration; in addition, it suppressed memory consolidation and reduced the spatial awareness for food of administered rodents [@pone.0105048-Friedman1], [@pone.0105048-Farr1]. The creation and removal of beta amyloid (Aβ) in rodents occurs through leptin modulation [@pone.0105048-Harvey1], [@pone.0105048-PerezGonzalez1], Aβ hippocampal removal was related to advanced object recognition [@pone.0105048-Whitmer1]. In addition, following ischemic challenge, neuronal survival in the hippocampus for Gerbils treated with leptin was greater than for gerbils without leptin treatment [@pone.0105048-Fewlass1]. Senescence-accelerated prone mice (SAMP8) with impaired learning and memory showed improved retention after hippocampal leptin injections [@pone.0105048-Greco1]. Through such rodent modeling, much has been learnt about leptin and cognition.

In humans, there remains controversy regarding the role of leptin in cognition. Lieb *et al.* indicated that the presence of increased hippocampal and whole brain volume were associated with higher plasma levels of leptin, suggesting that these higher plasma leptin levels associated with reduced incidence of AD [@pone.0105048-Warren1]. Controvertibly, dementia and AD development in older adults has been linked to low plasma leptin levels [@pone.0105048-Kanoski1]. Some studies have proved inconclusive regarding a difference in leptin between AD patients and controls, unless an ApoE4 allele was present [@pone.0105048-Lieb1].

Clinical attention to leptin has indicated that there is a statistical trend for increased cognitive scores to be associated with lower plasma leptin levels [@pone.0105048-Yan1]. Interestingly, when stratified by race and gender, excessive leptin in white men was associated with higher cognitive scores, as assessed by the Montreal Cognitive Assessment, while the opposite trend persisted amongst black men [@pone.0105048-Yan1]. AD patients with excessive low weight and decreased leptin plasma levels, implicates a hypothalamic level malfunction [@pone.0105048-Warren2]. Using the Modified Mini Mental State Exam, there is shown to be a protective quality of cellular leptin combating cognitive decline [@pone.0105048-Power1], [@pone.0105048-Holden1].

Finally, the increased gender difference regarding the incidence of AD in women can potentially be linked to the increased relative loss of adipokines in women than in men. Further gender differences in leptin occur regarding C-reactive protein (CRP) levels, highly correlated to leptin levels in women but not in men, which potentially links increased CRP levels to the increased relative adipose load for women [@pone.0105048-Kamogawa1]. Increased abdominal fat in Japanese men has been associated with mild cognitive impairment, the association inconclusive for Japanese women [@pone.0105048-Teng1].

We are cognizant of the extensive literature related to the effects of a number of hormones that we studied in this article and their respective roles of influencing leptin function: LH [@pone.0105048-Abdullah1], [@pone.0105048-Victor1]; FSH [@pone.0105048-Chakrabarti1]--[@pone.0105048-Geber1]; estradiol [@pone.0105048-Kanoski1], [@pone.0105048-Warren2], [@pone.0105048-Geber1].

Limitations {#s5}
===========

Although we started with a cohort of 796, after sub analysis, the lowest N was 194 due to missing values. Therefore, we caution any definitive interpretation of these data. Of the remaining 194 subjects, only 159 subjects had leptin values available for statistical analysis against P300 values. While we are encouraging more research in this area of important investigation, we suspect that leptin resistance may have a negative influence on global cognition in women based on the limited cohort of 159 women that was investigated.

We are cognizant that P300 latency may change as a function of pharmaceutical treatments, anxiety, and other physiological and behavioral factors. Thus, these factors must be considered seriously, and we propose caution in interpreting these data. Subsequently, in future studies we will also include Mini-Mental State Examination status, Wechsler Memory Scale tests, and other neurocognitive measures [@pone.0105048-Ajala1] along with electrophysiological measurements.

In pre- and post-menopausal women, we attempted to determine the relationship between plasma leptin levels and brain functionality as measured by P300. However, a PubMed literature search on 10-27-2013 revealed no articles on P300 measures and plasma leptin levels, in spite of many references associating leptin levels and genes with cognition [@pone.0105048-Fungfuang1]--[@pone.0105048-Kanaya1].

Specific demographics and an investigation of correlated BMI levels with leptin should be further expanded in future studies. We were unable to include additional demographic data such as body weight, height, and BMI among other fields. We are aware that these additional parameters may add to this study and better evaluate the changes in body composition among menopausal women in addition to cognitive function. A specialized study of this nature would be a significant follow-up to our current observations.

Conclusions {#s6}
===========

We are proposing that since leptin has been considered to be a cognitive enhancer, whereby cellular leptin acts on hippocampal cells (as one example) and improves performance in object recognition; leptin resistance and subsequent higher plasma levels should induce cognitive decline. As we expected, higher plasma leptin levels significantly and positively associated with a prolonged latency, which is a determinant for cognitive function.

Thus, our findings show significant association of higher plasma leptin levels, potentially due to leptin resistance, and prolonged P300 latency appears to be the first of such an association. Leptin resistance may delay electrophysiological processing of memory and attention.
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